MedTrace Logo

Probiotics in Respiratory Tract Infections in Children

NCT01510938 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 242

Last updated 2013-12-30

No results posted yet for this study

Summary

The purpose of this study is to assess the potential of probiotics in prevention of respiratory tract infections and their complications in children

Conditions

  • Infections, Respiratory Tract

Interventions

DIETARY_SUPPLEMENT

L. acidophilus DDS-1, B. lactis UABLA-12

1 g of probiotic will be reconstituted in 25-50 ml tepid water, juice or age specific baby food and immediately fed once a day (5 billion CFU/daily) for 2-weeks trial period or to the end of acute respiratory infection depending on whatever is longer.

DIETARY_SUPPLEMENT

Placebo

1 g in 25-50 ml of tepid water or juice fed once a day for 2-weeks trial period or to the end of acute respiratory infection depending on whatever is longer.

Sponsors & Collaborators

  • Lviv National Medical University

    lead OTHER

Principal Investigators

  • Sergei V Gerasimov, M.D., Ph.D. · Lviv National Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-05-31
Completion
2012-12-31

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01510938 on ClinicalTrials.gov